[1] |
Jauniaux E, Chantraine F, Silver RM, et al. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: epidemiology [J]. Int J Gynaecol Obstet, 2018, 140(3): 265-273. DOI: 10.1002/ijgo.12407.
|
[2] |
Solheim KN, Esakoff TF, Little SE, et al. The effect of cesarean delivery rates on the future incidence of placenta previa, placenta accreta, and maternal mortality [J]. J Matern Fetal Neonatal Med, 2011, 24(11): 1341-1346. DOI: 10.3109/14767058.2011.553695.
|
[3] |
Bodelon C, Bernabe-Ortiz A, Schiff MA, et al. Factors associated with peripartum hysterectomy [J]. Obstet Gynecol, 2009, 114(4): 927. DOI: 10.1097/AOG.0b013e3181ba039c.
|
[4] |
|
[5] |
Committee on Obstetric Practice. Committee opinion No. 529: placenta accreta [J]. Obstet Gynecol, 2012, 120(1): 207-211. DOI: 10.1097/AOG.0b013e318262e340.
|
[6] |
|
[7] |
Shamshirsaz AA, Fox KA, Salmanian B, et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach [J]. Am J Obstet Gynecol, 2015, 212(2): 218.e1-e9. DOI: 10.1016/j.ajog.2014.08.019.
|
[8] |
Sentilhes L, Kayem G, Chandraharan E, et al. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: conservative management [J]. Int J Gynaecol, 2018, 140(3): 291-298. DOI: 10.1002/ijgo.12410.
|
[9] |
Allen L, Jauniaux E, Hobson S, et al. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: nonconservative surgical management [J]. Int J Gynaecol Obstet, 2018, 140(3): 281-290. DOI: 10.1002/ijgo.12409.
|
[10] |
Jauniaux E, Bhide A, Kennedy A, et al. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: prenatal diagnosis and screening [J]. Int J Gynaecol, 2018, 140(3): 274-280. DOI: 10.1002/ijgo.12408.
|
[11] |
Jha P, Pōder L, Bourgioti C, et al. Society of Abdominal Radiology (SAR) and European Society of Urogenital Radiology (ESUR) joint consensus statement for MR imaging of placenta accreta spectrum disorders [J]. Eur Radiol, 2020, 30(5): 2604-2615. DOI: 10.1007/s00330-019-06617-7.
|
[12] |
Society of Gynecologic Oncology, American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine, Cahill AG, et al. Placenta accreta spectrum[J]. Am J Obstet Gynecol, 2018, 219(6): B2-B16. DOI: 10.1016/j.ajog.2018.09.042.
|
[13] |
Morel O, Collins SL, Uzan-Augui J, et al. International Society for Abnormally Invasive Placenta (IS-AIP). A proposal for standardized magnetic resonance imaging (MRI) descriptors of abnormally invasive placenta (AIP)-from the International Society for AIP [J]. Diagn Interv Imaging, 2019, 100(6): 319-325. DOI: 10.1016/j.diii.2019.02.004.
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
Expert Panel on MR Safety, Kanal E, Barkovich AJ, et al. ACR guidance document on MR safe practices: 2013 [J]. J Magn Reson Imaging, 2013, 37(3): 501-530. DOI: 10.1002/jmri.24011.
|
[19] |
Ray JG, Vermeulen MJ, Bharatha A, et al. Association between MRI exposure during pregnancy and fetal and childhood outcomes [J]. JAMA, 2016, 316(9): 952-961. DOI: 10.1001/jama.2016.12126.
|
[20] |
Horowitz JM, Berggruen S, McCarthy RJ, et al. When timing is everything: are placental MRI examinations performed before 24 weeks′ gestational age reliable? [J]. AJR Am J Roentgenol, 2015, 205(3): 685-692. DOI: 10.2214/AJR.14.14134.
|
[21] |
Zaghal AA, Hussain HK, Berjawi GA. MRI evaluation of the placenta from normal variants to abnormalities of implantation and malignancies [J]. J Magn Reson Imaging, 2019, 50(6): 1702-1717. DOI: 10.1002/jmri.26764.
|
[22] |
Goergen SK, Posma E, Wrede D, et al. Inter observer agreement and diagnostic performance of individual MRI criteria for diagnosis of placental adhesion disorders [J]. Clin Radiol, 2018, 73(10): 908.e1-908.e9. DOI: 10.1016/j.crad.2018.05.021.
|
[23] |
Lim PS, Greenberg M, Edelson MI, et al. Utility of ultrasound and MRI in prenatal diagnosis of placenta accreta: a pilot study [J]. AJR Am J Roentgenol, 2011, 197(6): 1506-1513. DOI: 10.2214/AJR.11.6858.
|
[24] |
Familiari A, Liberati M, Lim P, et al. Diagnostic accuracy of magnetic resonance imaging in detecting the severity of abnormal invasive placenta: a systematic review and Meta-analysis [J]. Acta Obstet Gynecol Scand, 2018, 97(5): 507-520. DOI: 10.1111/aogs.13258.
|
[25] |
Chen T, Xu XQ, Shi HB, et al. Conventional MRI features for predicting the clinical outcome of patients with invasive placenta [J]. Diagn Interv Radiol, 2017, 23(3): 173-179. DOI: 10.5152/dir.2016.16412.
|
[26] |
Alamo L, Anaye A, Rey J, et al. Detection of suspected placental invasion by MRI: do the results depend on observer′ experience? [J]. Eur J Radiol, 2013, 82(2): e51-e57. DOI: 10.1016/j.ejrad.2012.08.022.
|
[27] |
Jha P, Rabban J, Chen LM, et al. Placenta accreta spectrum: value of placental bulge as a sign of myometrial invasion on MR imaging [J]. Abdom Radiol (NY), 2019, 44(7): 2572-2581. DOI: 10.1007/s00261-019-02008-0.
|
[28] |
Allen BC, Leyendecker JR. Placental evaluation with magnetic resonance [J]. Radiol Clin North Am, 2013, 51(6): 955-966. DOI: 10.1016/j.rcl.2013.07.009.
|
[29] |
Bour L, Placé V, Bendavid S, et al. Suspected invasive placenta: evaluation with magneticresonance imaging [J]. Eur Radiol, 2014, 24(12): 3150-3160. DOI: 10.1007/s00330-014-3354-z.
|
[30] |
Masselli G, Gualdi G. MR imaging of the placenta: what a radiologist should know [J]. Abdom Imaging, 2013, 38(3): 573-587. DOI: 10.1007/s00261-012-9929-8.
|
[31] |
Elsayes KM, Trout AT, Friedkin AM, et al. Imaging of the placenta: a multimodality pictorial review [J]. Radiographics, 2009, 29(5): 1371-1391. DOI: 10.1148/rg.295085242.
|
[32] |
Bourgioti C, Zafeiropoulou K, Fotopoulos S, et al. MRI features predictive of invasive placenta with extrauterine spread in high-risk gravid patients: a prospective evaluation [J]. AJR Am J Roentgenol, 2018, 211(3): 701-711. DOI: 10.2214/AJR.17.19303.
|
[33] |
Chantraine F, Blacher S, Berndt S, et al. Abnormal vascular architecture at the placental-maternal interface in placenta increta [J]. Am J Obstet Gynecol, 2012, 207(3): 188.e1-e9. DOI: 10.1016/j.ajog.2012.06.083.
|
[34] |
Jauniaux E, Collins SL, Jurkovic D, et al. Accreta placentation: a systematic review of prenatal ultrasound imaging and grading of villous invasiveness [J]. Am J Obstet Gynecol, 2016, 215(6): 712-721. DOI: 10.1016/j.ajog.2016.07.044.
|
[35] |
Palacios-Jaraquemada JM. Caesarean section in cases of placenta praevia and accreta [J]. Best Pract Res Clin Obstet Gynaecol, 2013, 27(2): 221-232. DOI: 10.1016/j.bpobgyn.2012.10.003.
|
[36] |
Bourgioti C, Zafeiropoulou K, Fotopoulos S, et al. MRI prognosticators for adverse maternal and neonatal clinicaloutcome in patients at high risk for placenta accreta spectrum (PAS) disorders [J]. J Magn Reson Imaging, 2019, 50(2): 602-618. DOI: 10.1002/jmri.26592.
|
[37] |
Palacios-Jaraquemada JM, Bruno CH, Martín E. MRI in the diagnosis and surgical management of abnormal placentation [J]. Acta Obstet Gynecol Scand, 2013, 92(4): 392-397. DOI: 10.1111/j.1600-0412.2012.01527.x.
|
[38] |
Huang G, Wang X, Yu H, et al. A new surgical technique " cervical internal osplasty" in cesarean delivery for placenta previa accreta: a case-control study [J]. Medicine (Baltimore), 2019, 98(9): e14488. DOI: 10.1097/MD.0000000000014488.
|
[39] |
Chen M, Liu X, You Y, et al.InternalIliac artery balloon occlusion for placenta previa and suspected placenta accreta: arandomized controlled trial[J]. Obstet Gynecol, 2020, 135(5): 1112-1119. DOI: 10.1097/AOG.0000000000003792.PubMedPMID:32282608.
|